Opening Remarks

Brent Slava

Head of NewsdeskBenzinga

Spencer Israel

Executive ProducerBenzinga

Special Guest

Mark G. Charest, Ph.D

Founding Partner & Portfolio ManagerLifeSci Fund Management & Alphacentric Lifesci Healthcare Fund

Wellteq Digital Health (CSE: WTEQ) (OTCQB: WTEQF)

Scott Montgomery

CEOWellteq Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF)

Jaguar Health (NASDAQ: JAGX)

Lisa Conte

Founder, President, & CEOJaguar Health (NASDAQ: JAGX)

Medirom Healthcare Technologies (NASDAQ: MRM)

Andrew J. Barwicki

SVP, Investor RelationsMEDIROM Healthcare Technologies Inc. (NASDAQ: MRM)

Lobe Sciences (CSE: LOBE.CN) (OTCMKTS: GTSIF)

Philip J. Young

CEO & DirectorLobe Sciences (CSE: LOBE.CN) (OTCMKTS: GTSIF)

Inspira Technologies (NASDAQ: IINN)

Joe Hayon

Co-Founder & Chief Financial OfficerInspira Technologies (NASDAQ: IINN)

Nemaura Medical Corporate Update (NASDAQ: NMRD)

Dr. Faz Chowdhury

CEO & Chair of the BoardNemaura Medical (NASDAQ: NMRD)

Sorrento Therapeutics

Henry Ji, Ph.D.

Chairman, President, & CEOSorrento Therapeutics (NASDAQ: SRNE)

Lantern Pharma (NASDAQ: LTRN)

Panna Sharma

CEO, President & DirectorLantern Pharma (NASDAQ: LTRN)

Dyadic International (NASDAQ: DYAI)

Mark Emalfarb

President & CEODyadic International, Inc. (NASDAQ: DYAI)

Panel: Data and Rapid COVID-19 diagnostics and treatment

Amro Albanna

Co-Founder & CEOAditxt Inc. (NASDAQ: ADTX)

Henry Ji, Ph.D.

Chairman, President, & CEOSorrento Therapeutics (NASDAQ: SRNE)

Mark Emalfarb

President & CEODyadic International, Inc. (NASDAQ: DYAI)

Moderator

Jason Kolbert

Director of ResearchDawson James Securities

BriaCell (NASDAQ: BCTX, BCTXW) (TSX-V:BCT)

William V. Williams, MD, FACP

President, CEO, & DirectorBriaCell Therapeutics (NASDAQ: BCTX, BCTXW) (TSX-V:BCT)

Jamieson Bondarenko, CFA, CMT

Chairman of the BoardBriaCell (NASDAQ: BCTX, BCTXW) (TSX-V:BCT)

Tenax Therapeutics (NASDAQ: TENX)

Dr. Stuart Rich

Chief Medical OfficerTenax Therapeutics, Inc. (NASDAQ: TENX)

Chris Giordano

CEOTenax Therapeutics, Inc. NASDAQ: TENX

Michael Jebsen

CFOTenax Therapeutics, Inc. (NASDAQ: TENX)

Exclusive Interview with NLS Pharmaceutics AG

Alexander Zwyer

CEO & Co-FounderNLS Pharmaceutics Ltd. (NASDAQ: NLSP)

Moderator

Brent Slava

Head of NewsdeskBenzinga

Vivos Therapeutics (NASDAQ: VVOSO)

R. Kirk Huntsman

Chief Executive OfficerVivos Therapeutics, Inc. (NASDAQ: VVOS)

Schaeffer's Investment Research

Matthew Timpane, CMT

Senior Market StrategistSchaeffer's Investment Research

VolitionRx (NYSE American: VNRX)

Scott Powell

Executive Vice President & Head of Investor Relations; Chief Financial OfficerVolitionRx Limited; Volition America, Inc. (NYSE American: VNRX)

CloudDX

Robert Kaul

Founder & CEOCloudDX (OTCQB: CDXFF)

Neovasc (NASDAQ: NVCN)

Bill Little

COONeovasc Inc (NASDAQ: NVCN)

GBS Inc.

Harry Simeonidis

CEO, President, & DirectorGBS Inc. (NASDAQ: GBS)

Spiro Sakiris

Chief Financial OfficerGBS, Inc. (NASDAQ: GBS)

Closing Remarks

Brent Slava

Head of NewsdeskBenzinga